Drug Compare

Advertisement
 1  2  3  
  • Basic Info
Licensed from
Generic: arabinoxylan
treats Cancer and Diabetes
               



To get info about second drug, type a name above.


Category

Herbs & Supplements

Synonyms

Arabinoxylane, Arctostaphylos uva- ursi, AX, BioBran®, cinnaman AX, Cinnamomum cassia, Ganoderma lucidum, Hyphomycetes mycelia, kawaratake mushroom, MGN- 3, rice bran, shiitake mushroom, suehirotake mushroom.

Background

Altering the outer shell of rice bran using enzymes from Hyphomycetes mycelia mushroom extract produces Arabinoxylan compound. The product called MGN- 3 (or BioBran® in Japan) is a complex containing arabinoxylan as a major component.

Arabinoxylan has been found to improve immune reactions in diabetes and cancer patients. MGN- 3 may also be of potential value in treating AIDS patients or those patients undergoing chemotherapy. However, there is currently a lack of strong human scientific evidence to support the use of arabinoxylan for any indication.

Although presented by manufacturers as a generally safe substance without side effects at recommended doses, the United States Food and Drug Administration (FDA) ordered a permanent court order in 2004 against the marketing of MGN- 3, charging that it has been promoted as a drug treatment for cancer, diabetes and HIV.

Evidence

DISCLAIMER: These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.

Cancer (various types): Arabinoxylan has been studied in the treatment of cancer. Additional study is needed in this area.
Grade: C

Diabetes (type 2): There is currently a lack of scientific evidence investigating the role of arabinoxylan in diabetics. More study is needed before a firm recommendation can be made.
Grade: C

Tradition

WARNING: DISCLAIMER: The below uses are based on tradition, scientific theories, or limited research. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider. There may be other proposed uses that are not listed below.
Asthma, cardiovascular disease, chemotherapy adverse effects (adriamycin chemotherapy gastroprotection, cisplatin chemotherapy gastroprotection), chemotherapy- induced leucopenia (abnormally low white blood cell count), chronic fatigue syndrome, hepatitis, herpes zoster, high cholesterol, HIV, hypertension (high blood pressure), immune system deficiencies, insomnia, neurasthenia (nervous exhaustion), poisoning, post- herpetic neuralgia (nerve pain), respiratory disease, stress reduction, tonic (kidney), ulcers.
               
 1  2  3  
               
Advertisement